Added to YB: 2025-07-16
Pitch date: 2025-07-14
HIMS [bullish]
Hims & Hers Health, Inc.
-61.64%
current return
Author Info
No bio for this author
Company Info
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally.
Market Cap
$3.7B
Pitch Price
$53.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
22.69
P/E
32.11
EV/Sales
1.83
Sector
Health Care Providers and Services
Category
growth
Hims & Hers: Home lab tests for blood diagnosis are coming
HIMS: Entering blood diagnostics market via TrybeLabs acquisition. Home test kits will cover heart, hormones, liver, thyroid & cancer biomarkers. FDA-approved device provides smartphone health insights. Expands into $109.65B cancer diagnostics market (projected $199.54B by 2034). Bigger growth opportunity than GLP-1 drugs.
Read full article (3 min)